|Table of Contents|

[1] Zhang Yuanying, Guo Huishi, He Nongyue, et al. Applications of gene-chip for the detection of mutationsin cTnI gene associated with FHCM [J]. Journal of Southeast University (English Edition), 2005, 21 (3): 330-335. [doi:10.3969/j.issn.1003-7985.2005.03.017]
Copy

Applications of gene-chip for the detection of mutationsin cTnI gene associated with FHCM()
Share:

Journal of Southeast University (English Edition)[ISSN:1003-7985/CN:32-1325/N]

Volumn:
21
Issue:
2005 3
Page:
330-335
Research Field:
Biological Science and Medical Engineering
Publishing date:
2005-09-30

Info

Title:
Applications of gene-chip for the detection of mutationsin cTnI gene associated with FHCM
Author(s):
Zhang Yuanying1 3 Guo Huishi1 He Nongyue1 2 Gu Yu1 Yang Di2 Wan Wenhui2 Zhang Jinan2
1 State Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China
2 Research Institute of Cardiovascular Disease, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
3Jiangsu Institute of Cancer Research, Nanjing 210009, China
Keywords:
hypertrophic cardiomyopathy(HCM) gene-chip mutation hybridization
PACS:
Q81
DOI:
10.3969/j.issn.1003-7985.2005.03.017
Abstract:
Mutations in cardiac troponin I(cTnI)gene were assessed based on gene-chip technology.Special probes were designed to fabricate the low-density gene-chip, which could detect the mutations in exons 3, 5, 7, and 8 of the cTnI gene simultaneously.For each exon, two oligonucleotide sequences labeled with fluorescein at the 5′-end were designed, one(oligonucleotide Ⅰ)simulating the wild type and the other(oligonucleotide Ⅱ)simulating the mutant.Oligonucleotides Ⅰ and Ⅱ were mixed together to simulate the heterozygote.After optimizing the hybridization protocols, the fabricated gene-chip could detect the mutations in the exons of the cTnI gene with relative high sensitivity and specificity.The fully complementary probe gave a fluorescent signal almost 50% stronger than that of the one-base mismatched one, which is in accordance with the result from a theoretical estimate. An applicable special gene-chip is available to investigate and diagnose familial hypertrophic cardiomyopathy(FHCM)after further improvement.

References:

[1] Pardue M L, Gall J G.Molecular hybridization of radioactive DNA to the DNA of cytological preparations [J].Proc Natl Acad Sci USA, 1969, 64(2):600-604.
[2] McGall G H, Fidanza J A.Photolithographic synthesis of high-density oligonucleotide arrays [J].Methods Mol Biol, 2001, 170:71-101.
[3] Storhoff James J, Elghanian R, Mucic Robert C, et al.One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes [J].J Am Chem Soc, 1998, 120(9):1959-1964.
[4] Kozal M J, Shah N, Shen N, et al.Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays [J].Nat Med, 1996, 2(7):753-759.
[5] Chee M, Yang R, Hubbell E, et al.Accessing genetic information with high-density DNA arrays [J].Science, 1996, 274(5287):610-614.
[6] Southern E M, Maskos U, Elder J K.Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides:evaluation using experimental models [J].Genomics, 1992, 13(4):1008-1017.
[7] Thierfelder L, MacRae C, Watkins H, et al.A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2 [J].Proc Natl Acad Sci USA, 1993, 90(13):6270-6274.
[8] Symanski J D, Nishimura R A.The use of pacemakers in the treatment of cardiomyopathies [J].Curr Probl Cardiol, 1996, 21(6):385-443.

Memo

Memo:
Biographies: Zhang Yuanying(1978—), female, master;He Nongyue(corresponding author), male, doctor, professor, nyhe1958@163.com.
Last Update: 2005-09-20